Stay updated on Guselkumab in Active PsA: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as revision v3.8.1 instead of v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-18T03:07:04.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the completed guselkumab study record, including its design, eligibility criteria, outcomes, and record history, instead of a 403 error screen.
    Difference
    80%
    Check dated 2026-11-11T02:06:47.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:34:50.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    An NIH-wide notice about terminology changes appears above the 403 Forbidden page, and the site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:34:10.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study page remains a 403 Forbidden error, while the displayed site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:51:17.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content. This shows the page is currently blocked from access.
    Difference
    20%
    Check dated 2026-09-23T00:46:29.000Z thumbnail image

Stay in the know with updates to Guselkumab in Active PsA: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.